|
|
|
Volumn 21, Issue 8, 2011, Pages 1209-1215
|
|
[Osteoporosis treatment by anti-RANKL antibody].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENOSUMAB;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
CLINICAL TRIAL (TOPIC);
FRACTURE;
GENETICS;
HUMAN;
IMMUNOLOGY;
MOLECULARLY TARGETED THERAPY;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
FRACTURES, BONE;
HUMANS;
MOLECULAR TARGETED THERAPY;
OSTEOPOROSIS, POSTMENOPAUSAL;
RANK LIGAND;
|
|
EID: 80054841825
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
